Related Experiment Video
Updated: Feb 6, 2026

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
Triptolide induces protective autophagy and apoptosis in human cervical cancer cells by downregulating Akt/mTOR
Guangyi Qin1, Ping Li1, Zhuowei Xue1
1Department of Obstetrics and Gynaecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China.
Abstract:
Triptolide exhibits immunosuppressive, anti-inflammatory, antifertility and antineoplastic functions. However, the anticancer effect of triptolide on cervical cancer and the underlying mechanism remains to be fully understood. The present study assessed the mechanisms underlying the effect of triptolide on the viability and apoptosis of human cervical cancer cells. SiHa cells were treated with 12.5-100.0 nM triptolide for 12, 24 or 48 h. The present study demonstrated that triptolide inhibited viability and induced apoptosis in SiHa cells time- and dose-dependently. Furthermore, treatment with triptolide promoted autophagy and activated microtubule associated protein 1 light chain 3 α expression in SiHa cells. Triptolide treatment suppressed the expression of phosphorylated (p)-protein kinase B (Akt), p-mechanistic target of rapamycin (mTOR), and p-p70S6K, activated the expression of p-p38, mitogen-activated protein kinase (MAPK) and p53 and inhibited the expression of p-forkhead box O3 (Foxo3a) in SiHa cells. These results suggested that triptolide induces protective autophagy, suppresses cell viability and promotes apoptosis in human cervical cancer cells by inducing the autophagy-targeting phosphoinositide 3-kinase/Akt/mTOR, p38, MAPK, p53 and Foxo3a pathways.
Insights
Triptolide effectively reduces cervical cancer cell viability and promotes apoptosis. It also activates protective autophagy and influences key signaling pathways, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Triptolide is known for its diverse biological activities, including antineoplastic effects.
- The specific mechanisms of triptolide's action on cervical cancer remain incompletely understood.
Purpose of the Study:
- To investigate the effects of triptolide on human cervical cancer cell viability and apoptosis.
- To elucidate the underlying molecular mechanisms, including autophagy and key signaling pathways.
Main Methods:
- Human cervical cancer SiHa cells were treated with varying concentrations of triptolide (12.5-100.0 nM) for different durations (12, 24, 48 h).
- Cell viability, apoptosis, autophagy activation (LC3α expression), and the phosphorylation status of Akt, mTOR, p70S6K, p38 MAPK, p53, and Foxo3a were assessed.
Main Results:
- Triptolide significantly inhibited SiHa cell viability and induced apoptosis in a time- and dose-dependent manner.
- Triptolide treatment promoted autophagy, evidenced by increased microtubule-associated protein 1 light chain 3 alpha (LC3α) expression.
- Triptolide modulated key signaling pathways, suppressing p-Akt/mTOR/p70S6K, activating p-p38 MAPK/p53, and inhibiting p-Foxo3a.
Conclusions:
- Triptolide demonstrates potent anticancer effects against human cervical cancer cells by inhibiting viability and inducing apoptosis.
- The observed effects are mediated through the induction of protective autophagy and modulation of the PI3K/Akt/mTOR, p38 MAPK, p53, and Foxo3a signaling pathways.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Mechanisms of Retrovirus-induced Cancers

